Justin Eaton

Justin Eaton is the Founder and CEO of Toku Health, a cardiovascular supplement company focused on clinically relevant nattokinase dosing. After reviewing over 35 peer-reviewed studies on fibrinolytic enzymes, he developed Toku Flow which is the first nattokinase supplement to deliver the full 10,800 FU dose used in clinical research. Justin writes about heart health, enzyme science, and the gap between supplement marketing and clinical evidence. He believes proactive cardiovascular care shouldn't require a prescription.